0001140361-17-014934.txt : 20170405
0001140361-17-014934.hdr.sgml : 20170405
20170405163255
ACCESSION NUMBER: 0001140361-17-014934
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170403
FILED AS OF DATE: 20170405
DATE AS OF CHANGE: 20170405
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NEVRO CORP
CENTRAL INDEX KEY: 0001444380
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 562568057
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1800 BRIDGE PARKWAY
CITY: REDWOOD CITY
STATE: CA
ZIP: 94065
BUSINESS PHONE: 650-251-0005
MAIL ADDRESS:
STREET 1: 1800 BRIDGE PARKWAY
CITY: REDWOOD CITY
STATE: CA
ZIP: 94065
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Galligan Andrew H
CENTRAL INDEX KEY: 0001417976
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36715
FILM NUMBER: 17742962
MAIL ADDRESS:
STREET 1: C/O NEVRO CORP.
STREET 2: 1800 BRIDGE PARKWAY
CITY: REDWOOD CITY
STATE: CA
ZIP: 94065
4
1
doc1.xml
FORM 4
X0306
4
2017-04-03
0
0001444380
NEVRO CORP
NVRO
0001417976
Galligan Andrew H
C/O NEVRO CORP.
1800 BRIDGE PARKWAY
REDWOOD CITY
CA
94065
0
1
0
0
Chief Financial Officer
Common Stock
2017-04-03
4
S
0
6537
93.3866
D
30296
D
Common Stock
2017-04-03
4
S
0
9166
94.3235
D
21130
D
Common Stock
2017-04-03
4
S
0
14297
95.0403
D
6833
D
The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $92.82 to $93.81, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
Includes 6,833 restricted stock units.
The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $93.83 to $94.79, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $94.83 to $95.27, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
/s/ Andrew Galligan
2017-04-05